Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
421
-
Total 13F shares, excl. options
-
34.7M
-
Shares change
-
-98.6K
-
Total reported value, excl. options
-
$11B
-
Value change
-
-$16.1M
-
Put/Call ratio
-
1.16
-
Number of buys
-
203
-
Number of sells
-
-178
-
Price
-
$317.55
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2020
477 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2020.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 421 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.7M shares
of 152M outstanding shares and own 22.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.35M shares), VANGUARD GROUP INC (3.59M shares), BROWN CAPITAL MANAGEMENT LLC (1.5M shares), BAMCO INC /NY/ (1.49M shares), Ownership Capital B.V. (972K shares), Jackson Square Partners, LLC (959K shares), DF DENT & CO INC (926K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (921K shares), STATE STREET CORP (898K shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (876K shares).
This table shows the top 421 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.